Citadel Advisors - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 30 filers reported holding REPROS THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$19,000
+171.4%
28,818
+38.5%
0.00%
Q3 2017$7,000
-58.8%
20,800
-44.1%
0.00%
Q2 2017$17,000
-63.0%
37,200
-3.4%
0.00%
Q1 2017$46,000
+35.3%
38,500
+48.1%
0.00%
Q4 2016$34,000
-19.0%
26,000
+30.7%
0.00%
Q3 2016$42,000
+35.5%
19,900
-36.9%
0.00%
Q1 2016$31,000
-66.3%
31,535
-58.3%
0.00%
Q4 2015$92,000
+253.8%
75,605
+2419.3%
0.00%
Q1 2015$26,000
-90.0%
3,001
-88.5%
0.00%
Q4 2014$261,000
-76.9%
26,186
-77.1%
0.00%
-100.0%
Q3 2014$1,131,000
+883.5%
114,251
+1612.1%
0.00%
Q2 2014$115,000
-61.1%
6,673
-60.0%
0.00%
Q1 2014$296,000
-98.7%
16,678
-98.7%
0.00%
-100.0%
Q4 2013$22,858,000
-36.2%
1,249,093
-6.5%
0.03%
-44.4%
Q3 2013$35,810,000
+185.1%
1,336,206
+96.3%
0.05%
+145.5%
Q2 2013$12,562,000680,8220.02%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 978,800$1,292,0000.33%
Allegis Investment Advisors, LLC 344,487$455,0000.14%
GENERAL AMERICAN INVESTORS CO INC 589,768$778,0000.08%
Acrospire Investment Management LLC 23,177$31,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 268,130$354,0000.01%
Alambic Investment Management, L.P. 16,091$21,0000.00%
OXFORD ASSET MANAGEMENT LLP 51,359$68,0000.00%
Renaissance Technologies 716,413$946,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 2,700$4,0000.00%
Virtu KCG Holdings LLC 45,144$60,0000.00%
View complete list of REPROS THERAPEUTICS INC shareholders